
|Videos|April 14, 2023
How PSA Has Impacted the Use of ADT in Prostate Cancer
Tia Higano, MD, FACP, provides a historical perspective on prostate cancer the use of androgen-deprivation therapy (ADT) and on prostate-specific antigen (PSA) in diagnosis and monitoring.
Advertisement
January 2023 AbbVie Inc. Company Confidential
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
2
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
3
EV plus pembro approval reframes first conversation in MIBC diagnosis
4
Genomic Prostate Score may help refine risk assessment in localized prostate cancer
5














